| Rebecca Anne Jenetopulos, NP | |
|
61 Pierce St Ne Unit 428, Washington, DC 20002-2088 | |
| (786) 877-1642 | |
| Not Available |
| Full Name | Rebecca Anne Jenetopulos |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 61 Pierce St Ne Unit 428, Washington, District Of Columbia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023711322 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | R225435 (Maryland) | Primary |
| Entity Name | Mgmc Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891797148 PECOS PAC ID: 9537073119 Enrollment ID: O20031220000056 |
News Archive
Whether you hope to lose weight or just stay healthy, what you eat is a crucial factor. The right nutrients can not only trim your waistline, but also provide energy, improve your mood, and stave off disease. Now a Tel Aviv University researcher has found that it's not just what you eat - but when.
Merck today announced that it has restructured its co-development and co-commercialization agreement with ARIAD Pharmaceuticals, Inc. for ridaforolimus, an investigational orally available mTOR inhibitor currently being evaluated for the treatment of multiple cancer types, to an exclusive license agreement.
We have been working very hard to have our Trillennium Medical Imaging System ready to go to market. As most are aware we have been waiting for the Duke Study to be published in the ADVANCES IN SKIN AND WOUND CARE PUBLICATION JOURNAL. While everything has been submitted to the publisher and there have been two rounds of questions and clarifications resubmitted, we are confident and excited that we will have the results published in August or September.
No one really wants the short end of the stick, in this case the short end of a chromosome. Telomeres, which are DNA-protein complexes at the ends of chromosomes, can be thought of as protein "caps" that protect chromosomes from deteriorating and fusing with neighboring chromosomes.
iTherX, a pharmaceutical company dedicated to discovering and developing a new class of therapies for hepatitis C, today announced that it has commenced patient recruitment in an open-label, proof-of-concept Phase 1b study of its lead compound ITX-5061 in liver transplant patients with hepatitis C virus infection.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rebecca Anne Jenetopulos, NP 61 Pierce St Ne Unit 428, Washington, DC 20002-2088 Ph: () - | Rebecca Anne Jenetopulos, NP 61 Pierce St Ne Unit 428, Washington, DC 20002-2088 Ph: (786) 877-1642 |
News Archive
Whether you hope to lose weight or just stay healthy, what you eat is a crucial factor. The right nutrients can not only trim your waistline, but also provide energy, improve your mood, and stave off disease. Now a Tel Aviv University researcher has found that it's not just what you eat - but when.
Merck today announced that it has restructured its co-development and co-commercialization agreement with ARIAD Pharmaceuticals, Inc. for ridaforolimus, an investigational orally available mTOR inhibitor currently being evaluated for the treatment of multiple cancer types, to an exclusive license agreement.
We have been working very hard to have our Trillennium Medical Imaging System ready to go to market. As most are aware we have been waiting for the Duke Study to be published in the ADVANCES IN SKIN AND WOUND CARE PUBLICATION JOURNAL. While everything has been submitted to the publisher and there have been two rounds of questions and clarifications resubmitted, we are confident and excited that we will have the results published in August or September.
No one really wants the short end of the stick, in this case the short end of a chromosome. Telomeres, which are DNA-protein complexes at the ends of chromosomes, can be thought of as protein "caps" that protect chromosomes from deteriorating and fusing with neighboring chromosomes.
iTherX, a pharmaceutical company dedicated to discovering and developing a new class of therapies for hepatitis C, today announced that it has commenced patient recruitment in an open-label, proof-of-concept Phase 1b study of its lead compound ITX-5061 in liver transplant patients with hepatitis C virus infection.
› Verified 3 days ago
Ms. Janet E Jumper, N.P. Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, 4b42, Washington, DC 20010 Phone: 202-877-7462 | |
Arlyne E Heerlein, N.P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Us Dept Ofstate, 2401 E St., Nw, Washington, DC 20522 Phone: 202-663-2453 Fax: 202-663-3247 | |
Seble Yirga, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3800 Reservoir Rd Nw, Washington, DC 20007 Phone: 202-444-7265 Fax: 202-444-4208 | |
Daniel Richard Stairiker, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 5255 Loughboro Rd Nw, Washington, DC 20016 Phone: 202-537-4000 | |
Monica Elston, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Rd Nw # 3phc, Washington, DC 20007 Phone: 202-444-8531 | |
Sarah Katkhouda, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1627 I St Nw Ste 800, Washington, DC 20006 Phone: 202-204-7092 | |
Ms. Desiree Rivas, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 220 I St Ne, Washington, DC 20002 Phone: 703-867-2503 |